Skip to Content

APO 117 (Terazosin Hydrochloride 5 mg)

Pill with imprint APO 117 is Red, Capsule-shape and has been identified as Terazosin Hydrochloride 5 mg. It is supplied by Apotex Corp..

Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO 117

Terazosin hydrochloride 5 mg APO 117
Terazosin hydrochloride 5 mg APO 117 Front
Terazosin hydrochloride 5 mg APO 117 Back
Terazosin hydrochloride 5 mg APO 117
Terazosin hydrochloride 5 mg APO 117

Terazosin Hydrochloride

Imprint
APO 117
Strength
5 mg
Color
Red
Size
14.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antiadrenergic agents, peripherally acting
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Apotex Corp.
National Drug Code (NDC)
60505-0117
Inactive Ingredients
lactose monohydrate, corn starch, stearic acid, magnesium silicate, ammonia, ferrosoferric oxide, potassium hydroxide, propylene glycol, shellac, D&C Red No. 28, FD&C Red No. 40, gelatin, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.